The disease control authorities announced that they may introduce the adapted, so-called ‘Omicron-specific COVID-19 vaccines’ as newly introduced amounts if the vaccines receive marketing authorization.

In other words, if Moderna’s ‘Moderna Spikevax-2 inj.’ and Pfizer’s ‘Comirnaty-2 inj.’ that are being reviewed by the Ministry of Food and Drug Safety are approved, the authorities will bring in these vaccines as newly procured vaccines.

On the 9th, the Korea Disease Control and Prevention Agency responded so to a written QA on pending issues related to COVID-19 that was submitted by members of the National Assembly’s Health and Welfare Committee.

Adapted vaccine